Navigation Links
Transcept Pharmaceuticals Reports First Quarter 2009 Financial Results
Date:5/13/2009

ranscept has been working to establish a collaboration with a primary care marketing partner in the United States. In this regard, Transcept is currently engaged in discussions with potential marketing partners, but cannot predict whether such discussions will result in a collaboration, or the timing or terms under which any such collaboration would be established. If Transcept does not enter into a U.S. primary care marketing collaboration prior to the launch of Intermezzo(R), Transcept believes it would have the financial resources to carry out its plans to commercialize Intermezzo(R) on its own.

First Quarter 2009 Financial Results

Research and development expenses for the quarter ended March 31, 2009 were $2.2 million, compared to $3.6 million for the same period in 2008. The $1.4 million decrease is primarily attributable to lower Intermezzo(R) development costs, the majority of which were incurred prior to the submission of the NDA on September 30, 2008. Research and development expenses included non-cash stock compensation expense in accordance with Statement of Financial Accounting Standards No. 123R (SFAS No. 123R) of approximately $49,000 for the quarter ended March 31, 2009 and $64,000 for the quarter ended March 31, 2008.

General and administrative expenses for the quarter ended March 31, 2009 were $4.2 million, compared to $1.5 million for the same period in 2008. The $2.7 million increase consists of higher professional fees to operate as a public company, increased personnel costs primarily in marketing and administration, increased market research expenses and an increase in operational expenses associated with the addition of the Novacea office space in South San Francisco. General and administrative expenses included non-cash stock compensation expense in accordance with SFAS No. 123R of approximately $169,000 for the quarter ended March 31, 2009, as comp
'/>"/>

SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Transcept Pharmaceuticals Appoints Joseph T. Kennedy as General Counsel
2. Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results
3. Transcept Pharmaceuticals to Report Fourth Quarter 2008 Results
4. Transcept Pharmaceuticals to Present at Two Upcoming Conferences
5. Transcept Pharmaceuticals, Inc. Completes Merger with Novacea, Inc.
6. Transcept Pharmaceuticals to Participate on Drug Delivery Investor Panel
7. Transcept Pharmaceuticals, Inc. to Present at the 20th Annual Piper Jaffray Health Care Conference
8. Transcept Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference
9. Transcept Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
10. Transcept Pharmaceuticals to Present at Cowen and Companys 27th Annual Health Care Conference in Boston
11. Transcept Pharmaceuticals to Present at the Susquehanna Financial Groups SIGnificant Investment Options in Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Home Care Assistance of Centennial , a ... has received the Certified – Trusted Provider distinction from ... commitment to client satisfaction. , “Our goal at Home ... the South Metro Denver area are receiving the best ... Care Assistance of Centennial. “Home Care Pulse not ...
(Date:8/21/2014)... health authorities need to ensure that experimental drugs to ... of randomized controlled trials, according to a new Viewpoint, ... August, 2014]. , Leading bioethicists Professor Ezekiel ... Dr Annette Rid, of King,s College London, UK, outline ... if experimental drugs are to be deployed in the ...
(Date:8/21/2014)... 2014 Dr. Vasili Gatsinaris, ... was recently recognized as one of the ... field of workers’ compensation. , The list ... Occupational Medicine Conference was created by polling ... case managers, disability specialists, physical therapists, rehabilitation ...
(Date:8/21/2014)... 21, 2014 According to a new ... Optics Market-Global Industry Analysis, Size, Share, Growth, Trends and ... market was valued at USD 863.1 million in 2013 ... 7.6% from 2013 to 2019, to reach an estimated ... medical fiber optics market is witnessing significant growth due ...
(Date:8/21/2014)... 21, 2014 The worlds of personal ... an exciting chance to grab free products. BaliniSports ... from Tom's of Maine with all qualifying purchases for ... our environmentally friendly yoga apparel is simply perfect,” said ... promotion between the two brands is intended to give ...
Breaking Medicine News(10 mins):Health News:Home Care Assistance of Centennial Receives Home Care Pulse Certified – Trusted Provider Distinction 2Health News:Home Care Assistance of Centennial Receives Home Care Pulse Certified – Trusted Provider Distinction 3Health News:The Lancet: Experimental Ebola drugs must be fairly distributed and tested ethically in clinical trials 2Health News:Dr. Vasili Gatsinaris Named One of the Top 50 Most Influential in Workers’ Compensation 2Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 2Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 3Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 4Health News:Tom's of Maine Partner up with BaliniSports Yoga Apparel 2
... 25 Videos Airing on Exclusive Statewide On-Demand Channel, ... the winner of the YouCare video contest. Rachel Sbrissa ... video that shares why,she chooses not to smoke. Sbrissa,s ... radiation for lung cancer when the,video was being created, ...
... Popular Series Begin Monday, July 14, on ... Television,s Home for Medical Mysteries -, SILVER SPRING, ... emergency room stories to television with,MYSTERY ER, the popular medical ... second season premieres 10 suspense-packed episodes,showcasing the life-threatening drama of ...
... - Company Expects to Submit Complete Response by ... 30 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS;,NASDAQ: DDSS) ... response from,the U.S. Food and Drug Administration (FDA) ... the Agency,s Approvable Letter for its once-daily,tramadol formulation ...
... insurance consulting service reports that "Republican candidate John ... to buying a computers or cars" saying competition ... care proposal of the presumptive Republican presidential nominee ... employer-sponsored system; it will make things worse, said ...
... autism spectrum disorder (ASD) frequently struggle to fit into a world ... find for adults than for children. SIMmersion LLC is hoping ... of its simulation software catered to practicing and strengthening communication skills. ... ...
... to reduce pain in newborns undergoing painful procedures ... (venipuncture) for the newborn screening test but not ... co-authors. , In this double-blind, randomized controlled ... Hospital, researchers found that "sucrose reduced overall pain ...
Cached Medicine News:Health News:Grandmother is Inspiration for Winner of Tobacco Free Florida YouCare Contest 2Health News:MYSTERY ER Season 2 Takes Viewers Behind the Curtain for Real-Life Medical Mysteries on Discovery Health 2Health News:MYSTERY ER Season 2 Takes Viewers Behind the Curtain for Real-Life Medical Mysteries on Discovery Health 3Health News:Labopharm Receives Response from FDA Regarding its Once-Daily Tramadol Product 2Health News:Labopharm Receives Response from FDA Regarding its Once-Daily Tramadol Product 3Health News:Florida Health Insurance Analyst says McCain's Group Health Ideas Bad for Employees 2Health News:Florida Health Insurance Analyst says McCain's Group Health Ideas Bad for Employees 3Health News:New Intervention for Adults with Autism Spectrum Disorder Prototype Completed by SIMmersion LLC 2Health News:New Intervention for Adults with Autism Spectrum Disorder Prototype Completed by SIMmersion LLC 3
(Date:8/21/2014)... SAN FRANCISCO , Aug. 21, 2014 ... U.S. Food and Drug Administration (FDA) has ... to detect atrial fibrillation (AFib), the most ... analysis process (algorithm) instantly detects if patients ... recordings taken on the mobile phone based ...
(Date:8/21/2014)...  The board of directors of VirtualScopics, Inc. (NASDAQ: ... trial imaging solutions, today announced that James Groff ... immediately.  Mr. Groff has held the role of acting ... in January 2006 as an accounting manager and was ... the board of VirtualScopics asked Jim to assume the ...
(Date:8/21/2014)... , Aug. 21, 2014 /CNW/ - Bedrocan Cannabis ... three independent members to its Board of Directors, ... experience of the company, a leading licensed producer ... . Internationally, Bedrocan has 13 years, experience in ... in seven countries, including Canada. ...
Breaking Medicine Technology:AliveCor Receives First FDA Clearance to Detect a Serious Heart Condition in an ECG on a Mobile Device 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 3VirtualScopics, Inc. Names James Groff Chief Financial Officer 4Senior Life Sciences Executives Join Bedrocan as Independent Directors 2Senior Life Sciences Executives Join Bedrocan as Independent Directors 3
... BEIJING, Oct. 24 /PRNewswire-Asia-FirstCall/ -- Sinovac Biotech Ltd. (Nasdaq: ... products in China, announced today that it has been ... Prevention (Beijing CDC) as one of the five manufacturers ... Beijing. As part of the bidding process, ...
... 24 The National Community Pharmacists ... Jaeger as Executive Vice President and CEO, heralding ... the association,s recent accomplishments and lead it to ... of, independent community pharmacies and the patients they ...
Cached Medicine Technology:Sinovac Selected by Beijing CDC to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens 2Sinovac Selected by Beijing CDC to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens 3NCPA Announces Kathleen Jaeger as CEO 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: